Literature DB >> 10799995

Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression.

A Arís1, J X Feliu, A Knight, C Coutelle, A Villaverde.   

Abstract

A recombinant, multifunctional protein has been designed for optimized, cell-targeted DNA delivery and gene expression in mammalian cells. This hybrid construct comprises a viral peptide ligand for integrin alpha(V)beta(3) binding, a DNA-condensing poly-L-lysine domain, and a complete, functional beta-galactosidase protein that serves simultaneously as purification tag and DNA-shielding agent. This recombinant protein is stable; it has been produced successfully in Escherichia coli and can be purified in a single step by affinity chromatography. At optimal molar ratios, mixtures of this vector and a luciferase-reporter plasmid form stable complexes that transfect cultured cells. After exposure to these cell-targeted complexes, steady levels of gene expression are observed for more than 3 days after transfection, representing between 20 and 40% of those achieved with untargeted, lipid-based DNA-condensing agents. The principle to include viral motifs for cell infection in single polypeptide recombinant proteins represents a promising approach towards the design of non-viral modular DNA transfer vectors that conserve the cell-target- ing specificity of native viruses and that do not need further processing after bioproduction in a recombinant host. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799995     DOI: 10.1002/(sici)1097-0290(20000620)68:6<689::aid-bit13>3.0.co;2-a

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

Review 1.  Controlled release from recombinant polymers.

Authors:  Robert Price; Azadeh Poursaid; Hamidreza Ghandehari
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 2.  Development of recombinant cationic polymers for gene therapy research.

Authors:  Brenda F Canine; Arash Hatefi
Journal:  Adv Drug Deliv Rev       Date:  2010-04-14       Impact factor: 15.470

3.  Intelligent biosynthetic nanobiomaterials (IBNs) for hyperthermic gene delivery.

Authors:  Tze-Haw Howard Chen; Younsoo Bae; Darin Y Furgeson
Journal:  Pharm Res       Date:  2007-08-29       Impact factor: 4.200

4.  Neuroprotection from NMDA excitotoxic lesion by Cu/Zn superoxide dismutase gene delivery to the postnatal rat brain by a modular protein vector.

Authors:  Hugo Peluffo; Laia Acarin; Anna Arís; Pau González; Antoni Villaverde; Bernardo Castellano; Berta González
Journal:  BMC Neurosci       Date:  2006-04-25       Impact factor: 3.288

5.  Comparative analysis of lentiviral vectors and modular protein nanovectors for traumatic brain injury gene therapy.

Authors:  María Luciana Negro-Demontel; Paolo Saccardo; Cecilia Giacomini; Rafael Joaquín Yáñez-Muñoz; Neus Ferrer-Miralles; Esther Vazquez; Antonio Villaverde; Hugo Peluffo
Journal:  Mol Ther Methods Clin Dev       Date:  2014-10-15       Impact factor: 6.698

6.  DNA vaccines: improving expression of antigens.

Authors:  Helen S Garmory; Katherine A Brown; Richard W Titball
Journal:  Genet Vaccines Ther       Date:  2003-09-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.